{"organizations": [], "uuid": "c2b05ee60bab3e4d558042d48bf7dab436d13ddd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180413.html", "section_title": "Archive News &amp; Video for Friday, 13 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mauna-kea-cellvizio-demonstrates-s/brief-mauna-kea-cellvizio-demonstrates-superior-identification-of-patients-at-risk-for-esophageal-cancer-idUSFWN1RP172", "country": "US", "domain_rank": 408, "title": "BRIEF-Mauna Kea Cellvizio Demonstrates Superior Identification Of Patients At Risk For Esophageal Cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-13T14:11:00.000+03:00", "replies_count": 0, "uuid": "c2b05ee60bab3e4d558042d48bf7dab436d13ddd"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mauna-kea-cellvizio-demonstrates-s/brief-mauna-kea-cellvizio-demonstrates-superior-identification-of-patients-at-risk-for-esophageal-cancer-idUSFWN1RP172", "ord_in_thread": 0, "title": "BRIEF-Mauna Kea Cellvizio Demonstrates Superior Identification Of Patients At Risk For Esophageal Cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 13 (Reuters) - MAUNA KEA TECHNOLOGIES SAS:\n* MAUNA KEA TECHNOLOGIES’ CELLVIZIO® DEMONSTRATES SUPERIOR IDENTIFICATION OF PATIENTS AT RISK FOR ESOPHAGEAL CANCER COMPARED TO CURRENT DIAGNOSTIC STANDARD\n* RESULTS FROM NEW CLINICAL STUDY THAT ENROLLED 172 PATIENTS AT 8 NON-ACADEMIC CENTERS IN UNITED-STATES Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-13T14:11:00.000+03:00", "crawled": "2018-04-14T13:40:18.002+03:00", "highlightTitle": ""}